Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current approaches to the management of non-Hodgkin's lymphoma.

Literature DB >> 9728598

Current approaches to the management of non-Hodgkin's lymphoma.

Abstract

Non-Hodgkin's lymphoma (NHL) is a complex malignancy with many different clinical presentations, histologies, and varied treatment options depending on the histologic type and other prognostic factors. This article focuses on the major histologic subtypes of NHL with discussion of the natural history of each and information on various treatment options.

Entities: Disease

Mesh：

Year: 1998 PMID： 9728598

Source DB: PubMed Journal: Semin Oncol ISSN： 0093-7754 Impact factor: 4.929

Keyword Cloud
Cited

17 in total

1. Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification.

Authors: Indraneel Bhattacharyya; Hardeep K Chehal; Donald M Cohen; Samer Z Al-Quran
Journal: Head Neck Pathol Date: 2010-06-09

Review 2. Aggressive non-Hodgkin's lymphoma: economics of high-dose therapy.

Authors: Stephen M Beard; Lucy Wall; Louise Gaffney; Fiona Sampson
Journal: Pharmacoeconomics Date: 2004 Impact factor: 4.981

3. Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.

Authors: Steven I Park; Jaideep Shenoi; Shani M Frayo; Donald K Hamlin; Yukang Lin; D Scott Wilbur; Patrick S Stayton; Nural Orgun; Mark Hylarides; Franz Buchegger; Aimee L Kenoyer; Amanda Axtman; Ajay K Gopal; Damian J Green; John M Pagel; Oliver W Press
Journal: Clin Cancer Res Date: 2011-10-05 Impact factor: 12.531

4. Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma.

Authors: Steven I Park; Carolina P Lin; Natalie Ren; Steven P Angus; Dirk P Dittmer; Michael Foote; Trevor Parton; Aadra P Bhatt; Yuri D Fedoriw; Daniel P Roth; Marissa L Cann; Gary L Johnson; Blossom Damania
Journal: Target Oncol Date: 2019-10 Impact factor: 4.493

5. Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19).

Authors: M Herold; A Schulze; D Niederwieser; A Franke; H J Fricke; P Richter; M Freund; B Ismer; K Dachselt; C Boewer; V Schirmer; J Weniger; R Pasold; C Winkelmann; C Klinkenstein; M Schulze; H Arzberger; K Bremer; S Hahnfeld; A Schwarzer; C Müller; Chr Müller
Journal: J Cancer Res Clin Oncol Date: 2005-08-09 Impact factor: 4.553

6. Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.

Authors: Junji Hiraga; Tomohiro Kinoshita; Toshihito Ohno; Naoyoshi Mori; Haruhiko Ohashi; Shouko Fukami; Atsuhiko Noda; Atsushi Ichikawa; Tomoki Naoe
Journal: Int J Hematol Date: 2006-10 Impact factor: 2.490

10. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.

Authors: E Pelosi; P Pregno; D Penna; D Deandreis; A Chiappella; G Limerutti; U Vitolo; M Mancini; G Bisi; E Gallo
Journal: Radiol Med Date: 2008-04-14 Impact factor: 3.469